MAP2K1 and atrial fibrillation: Network pharmacology analysis revealed that EMP exerts its therapeutic effects on HUA‐CI through multi‐target and multi‐pathway mechanisms, particularly emphasizing the strong binding affinity between AF and MAP2K1.